FDA-2024-0061-V261
Minor variation for application FDA-2024-0061. Minor variation: Manufacturing Process Change for Lorlatenilib — minor update
Variation Number
FDA-2024-0061-V261
Type
Minor
Application
Change
Status
Active
Fee
€2,902
Submitted
2022-09-12
Approved
—
Description
Minor variation: Manufacturing Process Change for Lorlatenilib — minor update